Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Z Madden

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2023
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T CellsMatthew Z Madden, Xiang Ye, Channing Chi, et al.
Immunohorizons|December 22, 2022
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-TalkDalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2021
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway InflammationDiana C Contreras Healey, Jacqueline Y Cephus, Sierra M Barone, et al.
Cell Reports|February 9, 2016
ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNAHui Zhang, PamelaSara E Head, Waaqo Daddacha, et al.
Oncogene|March 18, 2025
Correction: EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
The Journal of Clinical Investigation|April 15, 2024
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesisMelissa M Wolf, Matthew Z Madden, Emily N Arner, et al.
Oncogene|May 28, 2020
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
Cell|November 6, 2018
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent MetabolismMarc O Johnson, Melissa M Wolf, Matthew Z Madden, et al.
Immunity|November 12, 2021
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and functionAyaka Sugiura, Gabriela Andrejeva, Kelsey Voss, et al.
The Journal of Clinical Investigation|October 15, 2024
Androgen signaling restricts glutaminolysis to drive sex-specific Th17 metabolism in allergic airway inflammationNowrin U Chowdhury, Jacqueline-Yvonne Cephus, Emely Henriquez Pilier, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Journal of Immunology (Baltimore, Md. : 1950)|June 21, 2023
Differential Effects of Glutamine Inhibition Strategies on Antitumor CD8 T CellsMatthew Z Madden, Xiang Ye, Channing Chi, et al.
Immunohorizons|December 22, 2022
Acly Deficiency Enhances Myelopoiesis through Acetyl Coenzyme A and Metabolic-Epigenetic Cross-TalkDalton L Greenwood, Haley E Ramsey, Phuong T T Nguyen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2021
Targeting In Vivo Metabolic Vulnerabilities of Th2 and Th17 Cells Reduces Airway InflammationDiana C Contreras Healey, Jacqueline Y Cephus, Sierra M Barone, et al.
Cell Reports|February 9, 2016
ATRIP Deacetylation by SIRT2 Drives ATR Checkpoint Activation by Promoting Binding to RPA-ssDNAHui Zhang, PamelaSara E Head, Waaqo Daddacha, et al.
Oncogene|March 18, 2025
Correction: EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
The Journal of Clinical Investigation|April 15, 2024
VHL loss reprograms the immune landscape to promote an inflammatory myeloid microenvironment in renal tumorigenesisMelissa M Wolf, Matthew Z Madden, Emily N Arner, et al.
Oncogene|May 28, 2020
EZH2 has a non-catalytic and PRC2-independent role in stabilizing DDB2 to promote nucleotide excision repairAllyson E Koyen, Matthew Z Madden, Dongkyoo Park, et al.
Cell|November 6, 2018
Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent MetabolismMarc O Johnson, Melissa M Wolf, Matthew Z Madden, et al.
Immunity|November 12, 2021
MTHFD2 is a metabolic checkpoint controlling effector and regulatory T cell fate and functionAyaka Sugiura, Gabriela Andrejeva, Kelsey Voss, et al.
The Journal of Clinical Investigation|October 15, 2024
Androgen signaling restricts glutaminolysis to drive sex-specific Th17 metabolism in allergic airway inflammationNowrin U Chowdhury, Jacqueline-Yvonne Cephus, Emely Henriquez Pilier, et al.
Pageof 3